Trials / Sponsors / Qlaris Bio, Inc.
Qlaris Bio, Inc.
Industry · 9 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Study of QLS-111-FDC in Open-Angle Glaucoma or Ocular Hypertension OAG - Open-Angle Glaucoma, OHT - Ocular Hypertension | Phase 2 / Phase 3 | 2026-03-18 |
| Recruiting | Single-site Pilot Study Evaluating the Effect of QLS-111 Ophthalmic Solution on Posterior Perfusion and Vessel Non-proliferative Diabetic Retinopathy (NPDR), Open-angle Glaucoma (OAG), Normal Tension Glaucoma (NTG) | Phase 2 | 2026-02-20 |
| Completed | Study of an Investigational Product, QLS-111, Provided as an Eyedrop, for Treatment of Normal Tension Glaucoma Normal Tension Glaucoma (NTG), Low-Tension Glaucoma, Bilateral, Low-Tension Glaucoma, Unspecified Eye | Phase 2 | 2025-08-13 |
| Completed | Qlaris Study of QLS-111 in Combination With a PGA for OAG and/or OHT Patients Open-angle Glaucoma (OAG), Ocular Hypertension (OHT), Glaucoma | Phase 2 | 2024-04-21 |
| Completed | Qlaris Phase 2 Study of QLS-111 in POAG And/or OHT Patients Primary Open Angle Glaucoma (POAG), Primary Open Angle Glaucoma of Both Eyes, Primary Open-Angle Glaucoma, Unspecified Eye | Phase 2 | 2024-03-05 |
| Completed | Safety and Tolerability Study of QLS-101 in Adolescents With Sturge-Weber Syndrome (SWS)-Related Glaucoma Due Sturge-Weber Syndrome, Glaucoma, Ocular Hypertension | Phase 2 | 2022-11-23 |
| Completed | A Study to Determine the Safety and Tolerability of 2 Concentrations of QLS-101 Sturge-Weber Syndrome (SWS), Glaucoma, Glaucoma Congenital | Phase 2 | 2021-10-19 |
| Completed | A Study to Evaluate Safety and Tolerability of QLS-101 in NTG Normal Tension Glaucoma (NTG) | Phase 2 | 2021-09-15 |
| Completed | Study to Evaluate QLS-101 Compared to Timolol Maleate Eye Drops in Subjects With High Eye Pressure (Glaucoma o Primary Open Angle Glaucoma, Ocular Hypertension | Phase 2 | 2021-03-31 |